Mycobacterium abscessus program (Recce Pharmaceuticals)

N/A

Report date: 2025/03/20 16:03:43
NME

Base Information

Drug NameMycobacterium abscessus program (Recce Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecce Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRecce Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsMycobacterium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A